Organization Profile

You just read:

iCo Therapeutics receives funding from the Government of Canada for the pre-clinical and clinical development of its Oral Amphotericin B Delivery System for the treatment of HIV/AIDS

News provided by

iCo Therapeutics Inc.

May 31, 2012, 12:45 ET